City

Chicago (1)

New York (1)

Suzhou (1)

Condition

Untreated Mantle Cell Lymphoma (2)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

The First Affiliated Hospital of Soochow University (1)

Weill Medical College of Cornell University (1)

Collaborator

Intervention

beam pretreatment (1)

bevacizumab (1)

chop (1)

rituximab (1)

zanubrutinib and rituximab (1)

zanubrutinib maintenance (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

untreated mantle cell lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Untreated Mantle Cell Lymphoma Trial in Suzhou (zanubrutinib and rituximab, BEAM pretreatment, zanubrutinib maintenance)

Recruiting

Untreated Mantle Cell Lymphoma

zanubrutinib and rituximab
+2 more

Suzhou, Jiangsu, China

the First Affiliated Hospital of Soochow University

Aug 16, 2022

Untreated Mantle Cell Lymphoma Trial in Chicago, New York (Bevacizumab, Rituximab, CHOP)

Completed

Has Results

Untreated Mantle Cell Lymphoma

Bevacizumab
+2 more

Chicago, Illinois
+1 more

Sep 15, 2017